Fig. 2: Comparative outcomes of peripheral blood and cerebrospinal fluid biomarkers in the meta-analysis. | npj Parkinson's Disease

Fig. 2: Comparative outcomes of peripheral blood and cerebrospinal fluid biomarkers in the meta-analysis.

From: A systematic review and meta-analysis of inflammatory biomarkers in Parkinson’s disease

Fig. 2: Comparative outcomes of peripheral blood and cerebrospinal fluid biomarkers in the meta-analysis.The alternative text for this image may have been generated using AI.

The peripheral blood (a) and cerebrospinal fluid (b) inflammatory markers with significant effect sizes (Hedges’ g) were displayed in comparisons for PD patients versus controls. Orange spots indicate Hedges’ g of each marker, and green and pink bars indicate the number of studies included. CCL chemokine (C-C motif) ligand, CRP C-reactive protein, CX3CL CX3 chemokine ligand, CXCL chemokine (C-X-C motif) ligand, IFN Interferon, IL interleukin, MCP monocyte chemoattractant protein, NT-pro BNP N-terminal pro-B-type natriuretic peptide, PD Parkinson’s disease, SDF stromal cell-derived factor, STNFR soluble tumour necrosis factor receptor, TNF tumour necrosis factor.

Back to article page